Drug interactions
Brentuximab + Stiripentol
Severity: Moderate
Brentuximab and Stiripentol: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Stiripentol inhibits CYP3A4 and P-glycoprotein but can also induce CYP3A4, so its effect on MMAE exposure is unpredictable. Increased exposure could worsen neutropenia and neuropathy, whereas reduced exposure could lessen efficacy.
What this interaction means in plain words
Brentuximab and Stiripentol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Brentuximab belongs to Oncology; Stiripentol belongs to Central Nervous System.
Why it happens
Mixed CYP3A4 inhibition/induction and P-gp inhibition altering MMAE disposition.
What to do
Monitor blood counts and neuropathy symptoms, and reduce or hold brentuximab for toxicity. Assess response to therapy.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Brentuximab and Stiripentol, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Brentuximab
- Bleomycin + Brentuximab Contraindicated
- Brentuximab + Dengue vaccine Major
- Brentuximab + Etrasimod Major
- Brentuximab + Idelalisib Major
- Brentuximab + Levoketoconazole Major
- Brentuximab + Nefazodone Major
Other interactions of Stiripentol
Frequently asked questions
Can I take Brentuximab with Stiripentol?
MediHelp rates the interaction as moderate. Brentuximab and Stiripentol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Stiripentol inhibits CYP3A4 and P-glycoprotein but can also induce CYP3A4, so its effect on MMAE exposure is unpredictable. Increased exposure could worsen neutropenia and neuropathy, whereas reduced exposure could lessen efficacy.
How serious is the interaction between Brentuximab and Stiripentol?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and neuropathy symptoms, and reduce or hold brentuximab for toxicity. Assess response to therapy.
What other medicines interact with Brentuximab?
MediHelp also lists interactions of Brentuximab with, for example, Bleomycin, Dengue vaccine, Etrasimod. The full list is on the Brentuximab page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
